Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Yves Girerd-Chambaz"'
Autor:
Maia A Rabaa, Yves Girerd-Chambaz, Kien Duong Thi Hue, Trung Vu Tuan, Bridget Wills, Matthew Bonaparte, Diane van der Vliet, Edith Langevin, Margarita Cortes, Betzana Zambrano, Corinne Dunod, Anh Wartel-Tram, Nicholas Jackson, Cameron P Simmons
Publikováno v:
eLife, Vol 6 (2017)
This study defined the genetic epidemiology of dengue viruses (DENV) in two pivotal phase III trials of the tetravalent dengue vaccine, CYD-TDV, and thereby enabled virus genotype-specific estimates of vaccine efficacy (VE). Envelope gene sequences (
Externí odkaz:
https://doaj.org/article/fe150f1a003d4095828a01b5f93ae894
Autor:
Raphael, Esson, Emanuel, Rodrigues De Sousa, Loic, Benair, Nicolas, Devard, Damien, Soulet, Audrey, Gillet, Isabelle, Bassard, Stephanie, Falque, Audrey, Chareyre, Morgane, Marmin, Yves, Girerd-Chambaz, Carine, Logvinoff, Martha Erika, Navarro Sanchez
Publikováno v:
Vaccine. 40:5641-5650
We assessed the genetic and phenotypic characteristics of a yellow fever vaccine candidate, which was cloned from a YF-VAX substrain selected for growth in Vero cells (vYF-247), during the manufacturing process from the master seed lot (MSL) and work
Autor:
Martha Erika Navarro Sanchez, Fabienne Piras-Douce, Nathalie Mantel, Manuel Vangelisti, Sylviane Gautheron, Franck Raynal, Alix Raquin, Yves Girerd-Chambaz
Publikováno v:
Vaccine
Highlights • vYF-247 was cloned from YF-VAX and adapted for growth in serum-free Vero cells. • vYF-247 selected by safety/immunogenicity/efficacy criteria in small animal models. • vYF-247 was less neurovirulent than Stamaril and YF-VAX. • vY
Autor:
Catherine Manin, Aure Saulnier, Yves Girerd-Chambaz, Catherine C. Berry, James E. Crowe, Nicholas Jackson, Sophie Naville, Valerie Lecouturier, Bruno Guy
Publikováno v:
Vaccine. 37:4601-4609
The recombinant yellow fever-17D-dengue virus, live, attenuated, tetravalent dengue vaccine (CYD-TDV) is licensed in several dengue-endemic countries. Although the vaccine provides protection against dengue, the level of protection differs by serotyp
Autor:
Yves Girerd-Chambaz, Jean-Michel Guigner, Ana A. Arteni, Catherine Vénien-Bryan, Ludovic Bannwarth, Frédéric Ronzon, Catherine Manin
Publikováno v:
Molecular Immunology
Molecular Immunology, 2015, 67 (2), pp.233-239. ⟨10.1016/j.molimm.2015.05.013⟩
Molecular Immunology, Elsevier, 2015, 67 (2), pp.233-239. ⟨10.1016/j.molimm.2015.05.013⟩
Molecular Immunology, 2015, 67 (2), pp.233-239. ⟨10.1016/j.molimm.2015.05.013⟩
Molecular Immunology, Elsevier, 2015, 67 (2), pp.233-239. ⟨10.1016/j.molimm.2015.05.013⟩
International audience; The inactivated polio vaccine (IPV) contains poliovirus (PV) samples that belong to serotypes 1, 2 and 3.All three serotypes contain the D-antigen, which induces protective antibodies. The antigenic structureof PVs consists of
Autor:
Nicolas Jackson, Francisco Maldonado-Arocho, Valerie Lecouturier, Ana P. Goncalvez, Raul C. Gomila, Harold Kleanthous, Diaz Fernando Martin, Nicolas Burdin, John Catalan, Maryann Giel-Moloney, Simon Delagrave, Ray Oomen, Konstantin V. Pugachev, Jon Heinrichs, Marie-Clotilde Bernard, Yves Girerd-Chambaz
Publikováno v:
Scientific Reports
Scientific Reports, Vol 8, Iss 1, Pp 1-11 (2018)
Scientific Reports, Vol 8, Iss 1, Pp 1-11 (2018)
Zika virus (ZIKV) is an emerging mosquito-borne pathogen representing a global health concern. It has been linked to fetal microcephaly and other birth defects and neurological disorders in adults. Sanofi Pasteur has engaged in the development of an
Autor:
Bruno Guy, Lindsay N. Carpp, Edith Langevin, Cameron P. Simmons, Paul T. Edlefsen, Andrew Fiore-Gartland, Peter B. Gilbert, Michal Juraska, Jason Shao, Nicholas Jackson, Carina Frago, Yves Girerd-Chambaz, Craig A. Magaret, Kien Duong Thi Hue, David Benkeser
Publikováno v:
Proceedings of the National Academy of Sciences. 115
Two phase 3 placebo-controlled trials of the CYD-TDV vaccine, evaluated in children aged 2-14 y (CYD14) and 9-16 y (CYD15), demonstrated vaccine efficacy (VE) of 56.5% and 60.8%, respectively, against symptomatic virologically confirmed dengue (VCD).
Autor:
Betzana Zambrano, Margarita Cortés, Edith Langevin, Cameron P. Simmons, Maia A. Rabaa, Diane van der Vliet, Trung Vu Tuan, Anh Wartel-Tram, Kien Duong Thi Hue, Bridget Wills, Matthew Bonaparte, Nicholas Jackson, Corinne Dunod, Yves Girerd-Chambaz
Publikováno v:
eLife, Vol 6 (2017)
eLife
eLife
This study defined the genetic epidemiology of dengue viruses (DENV) in two pivotal phase III trials of the tetravalent dengue vaccine, CYD-TDV, and thereby enabled virus genotype-specific estimates of vaccine efficacy (VE). Envelope gene sequences (
Autor:
Kien Duong Thi Hue, Bridget Wills, Anh Wartel-Tram, Margarita Cortés, Betzana Zambrano, Corinne Dunod, Edith Langevin, Cameron P. Simmons, Trung Vu Tuan, Maia A. Rabaa, Diane van der Vliet, Nicholas Jackson, Yves Girerd-Chambaz, Matthew Bonaparte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::50adddffe536e03604cee3c261251279
https://doi.org/10.7554/elife.24196.056
https://doi.org/10.7554/elife.24196.056
Autor:
Yves Mély, Ludovic Richert, Eric Larquet, Catherine Manin, Frédéric Ronzon, Nicolas Humbert, Yves Girerd-Chambaz
Publikováno v:
mAbs. 8(7)
Although the enzyme-linked immunosorbent assay (ELISA) is well established for quantitating epitopes on inactivated virions used as vaccines, it is less suited for detecting potential overlaps between the epitopes recognized by different antibodies r